VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q85488347  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010740.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q85488347‏
024 ‎‡a  0000-0003-0921-3144‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q85488347‏
100 0 ‎‡a  J Christopher Love‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  J Christopher Love‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A method for learning a sparse classifier in the presence of missing data for high-dimensional biological datasets‏
670 ‎‡a  Author's A Size-Selective Intracellular Delivery Platform.‏
670 ‎‡a  Author's Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.‏
670 ‎‡a  Author's Breast tissue regeneration is driven by cell-matrix interactions coordinating multi-lineage stem cell differentiation through DDR1‏
670 ‎‡a  Author's CBM-04PD-1 EXPRESSION IDENTIFIES EXHAUSTED TUMOR INFILTRATING REGULATORY T CELLS IN GLIOBLASTOMA.‏
670 ‎‡a  Author's CBM-05FUNCTIONAL DIFFERENCES BETWEEN PD-1+ AND PD-1– CD4+ T EFFECTOR CELLS IN HEALTHY DONORS AND PATIENTS WITH GLIOBLASTOMA.‏
670 ‎‡a  Author's Cell and fluid sampling microneedle patches for monitoring skin-resident immunity‏
670 ‎‡a  Author's Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.‏
670 ‎‡a  Author's Challenging the workhorse: Comparative analysis of eukaryotic micro-organisms for expressing monoclonal antibodies‏
670 ‎‡a  Author's Development of a High-Throughput Functional Screen Using Nanowell-Assisted Cell Patterning‏
670 ‎‡a  Author's Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects‏
670 ‎‡a  Author's Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage‏
670 ‎‡a  Author's Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.‏
670 ‎‡a  Author's Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis‏
670 ‎‡a  Author's Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity.‏
670 ‎‡a  Author's Host-Informed Expression of CRISPR Guide RNA for Genomic Engineering in Komagataella phaffii‏
670 ‎‡a  Author's Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection‏
670 ‎‡a  Author's Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires‏
670 ‎‡a  Author's Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus‏
670 ‎‡a  Author's Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing.‏
670 ‎‡a  Author's On-demand manufacturing of clinical-quality biopharmaceuticals‏
670 ‎‡a  Author's Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.‏
670 ‎‡a  Author's Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects.‏
670 ‎‡a  Author's Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies‏
670 ‎‡a  Author's Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms.‏
670 ‎‡a  Author's Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.‏
670 ‎‡a  Author's Single-Cell Detection of Secreted Aβ and sAPPα from Human IPSC-Derived Neurons and Astrocytes.‏
670 ‎‡a  Author's Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration‏
670 ‎‡a  Author's Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing‏
670 ‎‡a  Author's TBIO-18. LIQUID BIOPSY DETECTION OF GENOMIC ALTERATIONS IN PEDIATRIC BRAIN TUMORS FROM CELL FREE DNA IN PERIPHERAL BLOOD, CSF, AND URINE‏
670 ‎‡a  Author's TCR sequencing paired with massively parallel 3' RNA-seq reveals clonotypic T cell signatures‏
670 ‎‡a  Author's TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage‏
670 ‎‡a  Author's Tumor fraction in cell-free DNA as a biomarker in prostate cancer‏
670 ‎‡a  Author's Two Vaccines for Induce a B-Cell-Mediated Immune Response‏
670 ‎‡a  Author's What Is Your Conceptual Definition of "Cell Type" in the Context of a Mature Organism?‏
670 ‎‡a  Author's Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.‏
909 ‎‡a  (orcid) 0000000309213144‏ ‎‡9  1‏
919 ‎‡a  methodforlearningasparseclassifierinthepresenceofmissingdataforhighdimensionalbiologicaldatasets‏ ‎‡A  A method for learning a sparse classifier in the presence of missing data for high-dimensional biological datasets‏ ‎‡9  1‏
919 ‎‡a  sizeselectiveintracellulardeliveryplatform‏ ‎‡A  A Size-Selective Intracellular Delivery Platform.‏ ‎‡9  1‏
919 ‎‡a  associationofcellfreednatumorfractionandsomaticcopynumberalterationswithsurvivalinmetastatictriplenegativebreastcancer‏ ‎‡A  Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.‏ ‎‡9  1‏
919 ‎‡a  breasttissueregenerationisdrivenbycellmatrixinteractionscoordinatingmultilineagestemcelldifferentiationthroughddr1‏ ‎‡A  Breast tissue regeneration is driven by cell-matrix interactions coordinating multi-lineage stem cell differentiation through DDR1‏ ‎‡9  1‏
919 ‎‡a  cbm04pd1expressionidentifiesexhaustedtumorinfiltratingregulatorytcellsinglioblastoma‏ ‎‡A  CBM-04PD-1 EXPRESSION IDENTIFIES EXHAUSTED TUMOR INFILTRATING REGULATORY T CELLS IN GLIOBLASTOMA.‏ ‎‡9  1‏
919 ‎‡a  cbm05functionaldifferencesbetweenpd1+andpd1cd4+teffectorcellsinhealthydonorsandpatientswithglioblastoma‏ ‎‡A  CBM-05FUNCTIONAL DIFFERENCES BETWEEN PD-1+ AND PD-1– CD4+ T EFFECTOR CELLS IN HEALTHY DONORS AND PATIENTS WITH GLIOBLASTOMA.‏ ‎‡9  1‏
919 ‎‡a  cellandfluidsamplingmicroneedlepatchesformonitoringskinresidentimmunity‏ ‎‡A  Cell and fluid sampling microneedle patches for monitoring skin-resident immunity‏ ‎‡9  1‏
919 ‎‡a  celltypedependentalzheimersdiseasephenotypesprobingthebiologyofselectiveneuronalvulnerability‏ ‎‡A  Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.‏ ‎‡9  1‏
919 ‎‡a  challengingtheworkhorsecomparativeanalysisofeukaryoticmicroorganismsforexpressingmonoclonalantibodies‏ ‎‡A  Challenging the workhorse: Comparative analysis of eukaryotic micro-organisms for expressing monoclonal antibodies‏ ‎‡9  1‏
919 ‎‡a  developmentofahighthroughputfunctionalscreenusingnanowellassistedcellpatterning‏ ‎‡A  Development of a High-Throughput Functional Screen Using Nanowell-Assisted Cell Patterning‏ ‎‡9  1‏
919 ‎‡a  diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects‏ ‎‡A  Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects‏ ‎‡9  1‏
919 ‎‡a  erythrocyteefferocytosismodulatesmacrophagestowardsrecoveryafterintracerebralhemorrhage‏ ‎‡A  Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage‏ ‎‡9  1‏
919 ‎‡a  functionaldifferencesbetweenpd1+andpd1cd4+effectortcellsinhealthydonorsandpatientswithglioblastomamultiforme‏ ‎‡A  Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.‏ ‎‡9  1‏
919 ‎‡a  functionalinflammatoryprofilesdistinguishmyelinreactivetcellsfrompatientswithmultiplesclerosis‏ ‎‡A  Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis‏ ‎‡9  1‏
919 ‎‡a  generationoflonglivedbonemarrowplasmacellssecretingantibodiesspecificforthehiv1gp41membraneproximalexternalregionintheabsenceofpolyreactivity‏ ‎‡A  Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity.‏ ‎‡9  1‏
919 ‎‡a  hostinformedexpressionofcrisprguidernaforgenomicengineeringinkomagataellaphaffii‏ ‎‡A  Host-Informed Expression of CRISPR Guide RNA for Genomic Engineering in Komagataella phaffii‏ ‎‡9  1‏
919 ‎‡a  integratedsinglecellanalysisofmulticellularimmunedynamicsduringhyperacutehiv1infection‏ ‎‡A  Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection‏ ‎‡9  1‏
919 ‎‡a  longitudinalmultiparametersinglecellanalysisofmacaquesimmunizedwithpneumococcalproteinconjugatedorunconjugatedpolysaccharidevaccinesrevealsdistinctantigenspecificmemorybcellrepertoires‏ ‎‡A  Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires‏ ‎‡9  1‏
919 ‎‡a  molecularengineeringimprovesantigenqualityandenablesintegratedmanufacturingofatrivalentsubunitvaccinecandidateforrotavirus‏ ‎‡A  Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus‏ ‎‡9  1‏
919 ‎‡a  neutralizingantibodiesagainstwestnilevirusidentifieddirectlyfromhumanbcellsbysinglecellanalysisandnextgenerationsequencing‏ ‎‡A  Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing.‏ ‎‡9  1‏
919 ‎‡a  ondemandmanufacturingofclinicalqualitybiopharmaceuticals‏ ‎‡A  On-demand manufacturing of clinical-quality biopharmaceuticals‏ ‎‡9  1‏
919 ‎‡a  opportunitiesandchallengesofrealtimereleasetestinginbiopharmaceuticalmanufacturing‏ ‎‡A  Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.‏ ‎‡9  1‏
919 ‎‡a  peanutoralimmunotherapytransientlyexpandscirculatingarah2specificbcellswithahomologousrepertoireinunrelatedsubjects‏ ‎‡A  Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects.‏ ‎‡9  1‏
919 ‎‡a  primingagentstransientlyreducetheclearanceofcellfreednatoimproveliquidbiopsies‏ ‎‡A  Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies‏ ‎‡9  1‏
919 ‎‡a  reexaminingopportunitiesfortherapeuticproteinproductionineukaryoticmicroorganisms‏ ‎‡A  Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms.‏ ‎‡9  1‏
919 ‎‡a  scalablewholeexomesequencingofcellfreednarevealshighconcordancewithmetastatictumors‏ ‎‡A  Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.‏ ‎‡9  1‏
919 ‎‡a  singlecelldetectionofsecretedaβandsappαfromhumanipscderivedneuronsandastrocytes‏ ‎‡A  Single-Cell Detection of Secreted Aβ and sAPPα from Human IPSC-Derived Neurons and Astrocytes.‏ ‎‡9  1‏
919 ‎‡a  singlecelltranscriptomicatlasofthehumanretinaidentifiescelltypesassociatedwithagerelatedmaculardegeneration‏ ‎‡A  Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration‏ ‎‡9  1‏
919 ‎‡a  structuralalterationsdrivingcastrationresistantprostatecancerrevealedbylinkedreadgenomesequencing‏ ‎‡A  Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing‏ ‎‡9  1‏
919 ‎‡a  tbio18liquidbiopsydetectionofgenomicalterationsinpediatricbraintumorsfromcellfreednainperipheralbloodcsfandurine‏ ‎‡A  TBIO-18. LIQUID BIOPSY DETECTION OF GENOMIC ALTERATIONS IN PEDIATRIC BRAIN TUMORS FROM CELL FREE DNA IN PERIPHERAL BLOOD, CSF, AND URINE‏ ‎‡9  1‏
919 ‎‡a  tcrsequencingpairedwithmassivelyparallel3rnaseqrevealsclonotypictcellsignatures‏ ‎‡A  TCR sequencing paired with massively parallel 3' RNA-seq reveals clonotypic T cell signatures‏ ‎‡9  1‏
919 ‎‡a  tgfβ1modulatesmicroglialphenotypeandpromotesrecoveryafterintracerebralhemorrhage‏ ‎‡A  TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage‏ ‎‡9  1‏
919 ‎‡a  tumorfractionincellfreednaasabiomarkerinprostatecancer‏ ‎‡A  Tumor fraction in cell-free DNA as a biomarker in prostate cancer‏ ‎‡9  1‏
919 ‎‡a  2vaccinesforinduceabcellmediatedimmuneresponse‏ ‎‡A  Two Vaccines for Induce a B-Cell-Mediated Immune Response‏ ‎‡9  1‏
919 ‎‡a  whatisyourconceptualdefinitionofcelltypeinthecontextofamatureorganism‏ ‎‡A  What Is Your Conceptual Definition of "Cell Type" in the Context of a Mature Organism?‏ ‎‡9  1‏
919 ‎‡a  wholeexomesequencingofcellfreednaandcirculatingtumorcellsinmultiplemyeloma‏ ‎‡A  Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.‏ ‎‡9  1‏
996 ‎‡2  LC|nr 00024423
996 ‎‡2  SUDOC|194318745
996 ‎‡2  LC|no2019113501
996 ‎‡2  J9U|987007281070605171
996 ‎‡2  J9U|987007335900805171
996 ‎‡2  XA|14812
996 ‎‡2  ISNI|0000000497544628
996 ‎‡2  ISNI|0000000058090839
996 ‎‡2  CAOONL|ncf11187531
996 ‎‡2  LC|n 90641301
996 ‎‡2  BIBSYS|90080990
996 ‎‡2  NII|DA08320151
996 ‎‡2  LC|no2008033358
996 ‎‡2  CAOONL|ncf11523857
996 ‎‡2  LC|no2012072122
996 ‎‡2  ISNI|0000000094720957
996 ‎‡2  ISNI|0000000050570897
996 ‎‡2  NUKAT|n 2006093429
996 ‎‡2  DBC|87097969952860
996 ‎‡2  LC|n 2001011196
996 ‎‡2  ISNI|0000000445337918
996 ‎‡2  LC|n 86067722
996 ‎‡2  CAOONL|ncf11360644
996 ‎‡2  DNB|1191721221
996 ‎‡2  LC|n 94029129
996 ‎‡2  BNF|15034671
996 ‎‡2  LNB|LNC10-000338367
996 ‎‡2  SUDOC|192296418
996 ‎‡2  LC|nb2019000204
996 ‎‡2  DNB|1061327981
996 ‎‡2  NLA|000077141737
996 ‎‡2  CAOONL|ncf10992433
996 ‎‡2  LC|no2015105831
996 ‎‡2  DNB|1140536990
996 ‎‡2  SUDOC|254863213
996 ‎‡2  ISNI|0000000081738795
996 ‎‡2  LC|n 91011125
996 ‎‡2  ISNI|0000000467755141
996 ‎‡2  SUDOC|080535887
996 ‎‡2  ISNI|0000000041413435
996 ‎‡2  NTA|072837683
996 ‎‡2  SUDOC|131291017
996 ‎‡2  LIH|LNB:CF_z__y_;=CM
996 ‎‡2  LC|n 93012577
996 ‎‡2  BNF|15760505
996 ‎‡2  LC|no2023045263
996 ‎‡2  NTA|203235533
996 ‎‡2  BIBSYS|9051699
996 ‎‡2  ISNI|0000000497686896
996 ‎‡2  DBC|87097919481964
996 ‎‡2  ISNI|0000000052259883
996 ‎‡2  DBC|87097968648874
996 ‎‡2  DNB|171546326
996 ‎‡2  ISNI|0000000054027736
996 ‎‡2  CAOONL|ncf12125785
996 ‎‡2  RERO|A011826760
996 ‎‡2  NKC|mub2014823130
996 ‎‡2  ISNI|0000000433851418
996 ‎‡2  SUDOC|242160301
996 ‎‡2  ISNI|0000000030374987
996 ‎‡2  SUDOC|169467538
996 ‎‡2  LC|n 2010160371
996 ‎‡2  BNC|981058617780206706
996 ‎‡2  NII|DA19980560
996 ‎‡2  DNB|105543450X
996 ‎‡2  NII|DA08382498
996 ‎‡2  NUKAT|n 2011061358
996 ‎‡2  PLWABN|9811342613505606
996 ‎‡2  BNF|17859275
996 ‎‡2  NII|DA14874271
996 ‎‡2  CAOONL|ncf10647760
996 ‎‡2  LC|no2012158328
996 ‎‡2  BNF|10362344
996 ‎‡2  LC|nr2005023237
996 ‎‡2  DNB|1137627743
996 ‎‡2  PLWABN|9810627150005606
996 ‎‡2  LC|no2008168907
996 ‎‡2  BIBSYS|90800615
996 ‎‡2  NTA|160967228
996 ‎‡2  ISNI|000000004215878X
996 ‎‡2  LC|n 2016070183
996 ‎‡2  NUKAT|n 2010057647
996 ‎‡2  NYNYRILM|154265
996 ‎‡2  LC|no 00039787
996 ‎‡2  ISNI|0000000377400339
996 ‎‡2  LC|n 2008066271
996 ‎‡2  W2Z|1634281497987
996 ‎‡2  BNF|12106871
996 ‎‡2  LC|n 2008013589
996 ‎‡2  LIH|LNB:C_t__h__w_;=C_g_
996 ‎‡2  LC|n 86014041
996 ‎‡2  LC|no 98125461
996 ‎‡2  UIY|000024582
996 ‎‡2  ISNI|0000000030011617
996 ‎‡2  LC|no 95008376
996 ‎‡2  CAOONL|ncf10280923
996 ‎‡2  ISNI|0000000051361122
996 ‎‡2  ISNI|0000000063727347
996 ‎‡2  BIBSYS|1634281497987
996 ‎‡2  NKC|xx0237315
996 ‎‡2  LC|n 92097296
996 ‎‡2  ISNI|0000000076028326
996 ‎‡2  CAOONL|ncf10886940
996 ‎‡2  SUDOC|115821252
996 ‎‡2  LC|n 2016498186
996 ‎‡2  NUKAT|n 99025305
996 ‎‡2  LC|n 82214891
996 ‎‡2  LC|n 2018049877
996 ‎‡2  CAOONL|ncf11292232
996 ‎‡2  DNB|1045328014
996 ‎‡2  PLWABN|9810597292805606
996 ‎‡2  SUDOC|172767687
996 ‎‡2  ISNI|000000010870908X
996 ‎‡2  LC|no2016135849
996 ‎‡2  LC|no2012103480
996 ‎‡2  ISNI|0000000054264766
996 ‎‡2  DNB|104126345
996 ‎‡2  DNB|141886668
996 ‎‡2  PLWABN|9810561336005606
996 ‎‡2  ISNI|0000000082295842
996 ‎‡2  SUDOC|224560352
996 ‎‡2  LC|n 2014015019
996 ‎‡2  LC|nb2007020092
996 ‎‡2  PLWABN|9810583391005606
996 ‎‡2  ISNI|0000000047781263
996 ‎‡2  LC|n 2002103547
996 ‎‡2  NDL|00448085
996 ‎‡2  NDL|00448084
996 ‎‡2  NSK|000345792
996 ‎‡2  LC|n 85144657
996 ‎‡2  LC|no2007057981
996 ‎‡2  NII|DA13542232
996 ‎‡2  ISNI|0000000027695755
996 ‎‡2  RERO|A022883130
996 ‎‡2  DBC|87097991414023
996 ‎‡2  ISNI|0000000495663527
996 ‎‡2  NTA|227460812
996 ‎‡2  NKC|mzk20211100588
996 ‎‡2  BNF|13332004
996 ‎‡2  BIBSYS|99010345
996 ‎‡2  ISNI|0000000117484505
996 ‎‡2  ISNI|0000000024556063
996 ‎‡2  PTBNP|1781732
996 ‎‡2  RERO|A023335903
996 ‎‡2  LC|n 85138827
996 ‎‡2  SUDOC|131535846
996 ‎‡2  RERO|A009587006
996 ‎‡2  LC|nr 93021299
996 ‎‡2  LNB|LNC10-000090983
996 ‎‡2  BIBSYS|12008666
996 ‎‡2  ISNI|0000000031925496
996 ‎‡2  SUDOC|252829034
996 ‎‡2  DNB|140456910
996 ‎‡2  B2Q|0000113527
996 ‎‡2  ARBABN|000045145
996 ‎‡2  J9U|987007340863805171
996 ‎‡2  ISNI|000000008438737X
996 ‎‡2  LC|no2017071469
996 ‎‡2  DNB|132854767
996 ‎‡2  J9U|987007432483205171
996 ‎‡2  ISNI|0000000048590493
996 ‎‡2  J9U|987007347046905171
996 ‎‡2  LC|n 50043515
996 ‎‡2  LC|n 2015004845
996 ‎‡2  NTA|099576759
996 ‎‡2  CAOONL|ncf10701022
996 ‎‡2  CAOONL|ncf10592436
996 ‎‡2  LC|n 93801067
996 ‎‡2  J9U|987007376880205171
996 ‎‡2  BNF|15102498
996 ‎‡2  BNF|13978039
996 ‎‡2  DNB|1213052858
996 ‎‡2  SUDOC|098417924
996 ‎‡2  LC|nb 99140328
996 ‎‡2  PLWABN|9813627573605606
996 ‎‡2  DNB|1079691499
996 ‎‡2  NII|DA04425238
996 ‎‡2  LC|n 2009164583
996 ‎‡2  LC|n 2008013336
996 ‎‡2  NTA|171009746
996 ‎‡2  BIBSYS|90238333
996 ‎‡2  SUDOC|224919849
996 ‎‡2  LC|n 82220830
996 ‎‡2  ISNI|0000000054914853
996 ‎‡2  NKC|xx0236037
996 ‎‡2  J9U|987007443794905171
996 ‎‡2  LC|no2015057823
996 ‎‡2  LC|n 84130750
996 ‎‡2  LC|no2010026171
996 ‎‡2  RERO|A026954873
996 ‎‡2  LC|no2007126912
996 ‎‡2  LC|no2023085906
996 ‎‡2  LC|no2009150784
996 ‎‡2  LC|no2005064726
996 ‎‡2  SZ|1140536990
996 ‎‡2  RERO|A029017056
996 ‎‡2  NII|DA01281007
996 ‎‡2  B2Q|0000490240
996 ‎‡2  LC|n 93006870
996 ‎‡2  ISNI|0000000139976105
996 ‎‡2  ISNI|000000011754300X
996 ‎‡2  ISNI|0000000032094102
996 ‎‡2  ISNI|0000000040202038
996 ‎‡2  RERO|A012121136
996 ‎‡2  DNB|121613410
996 ‎‡2  LC|nr2006024837
996 ‎‡2  J9U|987007429314105171
996 ‎‡2  ISNI|0000000054751839
996 ‎‡2  RERO|A022927796
996 ‎‡2  NUKAT|n 2019045782
996 ‎‡2  LC|no2017166114
996 ‎‡2  LC|n 88163780
996 ‎‡2  LC|no 96003416
996 ‎‡2  LC|no2017136160
996 ‎‡2  ISNI|0000000073434134
996 ‎‡2  BNF|18165507
996 ‎‡2  ISNI|0000000499609683
996 ‎‡2  LC|no2012156173
996 ‎‡2  CAOONL|ncf10513906
996 ‎‡2  BNF|12256095
996 ‎‡2  ISNI|0000000041898073
996 ‎‡2  ISNI|0000000028101947
996 ‎‡2  NTA|339730501
996 ‎‡2  NTA|267143214
996 ‎‡2  LIH|LNB:DA_s_B;=BQ
996 ‎‡2  ISNI|0000000063197294
996 ‎‡2  ISNI|0000000140275576
996 ‎‡2  LC|no2016049941
996 ‎‡2  LC|no2024035314
996 ‎‡2  SUDOC|156910799
996 ‎‡2  LC|no2011002265
996 ‎‡2  LC|n 2012003041
996 ‎‡2  ISNI|0000000083416837
996 ‎‡2  LC|no2009069508
996 ‎‡2  LC|n 2016061917
996 ‎‡2  LC|nr 93021296
996 ‎‡2  LC|nr 93021297
996 ‎‡2  LC|nr 93021295
996 ‎‡2  BLBNB|000280202
996 ‎‡2  BLBNB|000280201
996 ‎‡2  LC|n 00092600
996 ‎‡2  BIBSYS|7054874
996 ‎‡2  DNB|1063743346
996 ‎‡2  LC|n 78004868
996 ‎‡2  NUKAT|n 2007115485
996 ‎‡2  NII|DA07324328
996 ‎‡2  ISNI|0000000047296858
996 ‎‡2  PTBNP|1816839
996 ‎‡2  PLWABN|9812446991005606
996 ‎‡2  DNB|1137297123
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏